These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25205308)

  • 21. Antiplatelet therapy with aspirin in acute ischaemic stroke.
    Sandercock P
    Thromb Haemost; 1997 Jul; 78(1):180-2. PubMed ID: 9198149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA
    Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.
    Vernooij MW; van der Lugt A; Ikram MA; Wielopolski PA; Niessen WJ; Hofman A; Krestin GP; Breteler MM
    Neurology; 2008 Apr; 70(14):1208-14. PubMed ID: 18378884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Medico-surgical treatments in ischemic cerebrovascular diseases].
    Fields WS
    Neurologia; 1988; 3(5):187-92. PubMed ID: 3078766
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does clopidogrel with aspirin after acute minor stroke or transient ischemic attack increase the risk of cerebral hemorrhage?
    Zheng H; Chen C; Hu Z; Yang L
    Chin Med J (Engl); 2014; 127(18):3352-3. PubMed ID: 25266540
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemorrhagic stroke, cerebral amyloid angiopathy, Down syndrome and the Boston criteria.
    Jastrzębski K; Kacperska MJ; Majos A; Grodzka M; Głąbiński A
    Neurol Neurochir Pol; 2015; 49(3):193-6. PubMed ID: 26048609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
    Dengler R; Diener HC; Schwartz A; Grond M; Schumacher H; Machnig T; Eschenfelder CC; Leonard J; Weissenborn K; Kastrup A; Haberl R;
    Lancet Neurol; 2010 Feb; 9(2):159-66. PubMed ID: 20060783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke.
    Fan YH; Zhang L; Lam WW; Mok VC; Wong KS
    Stroke; 2003 Oct; 34(10):2459-62. PubMed ID: 12958325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient focal neurological episodes, cerebral amyloid angiopathy, and intracerebral hemorrhage risk: looking beyond TIAs.
    Charidimou A; Baron JC; Werring DJ
    Int J Stroke; 2013 Feb; 8(2):105-8. PubMed ID: 23336261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial.
    Hong KS; Kim BJ; Lee JY; Kwon SU;
    Int J Stroke; 2015 Oct; 10(7):1153-8. PubMed ID: 26044566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial distribution of hemorrhages in cerebral amyloid angiopathy.
    Jellinger KA
    Ann Neurol; 2006 Jan; 59(1):215. PubMed ID: 16374827
    [No Abstract]   [Full Text] [Related]  

  • 35. Is the finding of the PROFESS study consistent with predictions of network meta-analysis?
    Lam SK; Owen A
    Eur Heart J; 2008 Oct; 29(20):2580. PubMed ID: 18799521
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspirin non-responders in Thai ischemic stroke/TIA patients.
    Dharmasaroja P
    J Med Assoc Thai; 2008 Jun; 91(6):818-21. PubMed ID: 18697379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex difference in the antiplatelet effect of aspirin in patients with stroke.
    Cavallari LH; Helgason CM; Brace LD; Viana MA; Nutescu EA
    Ann Pharmacother; 2006 May; 40(5):812-7. PubMed ID: 16608908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral amyloid angiopathy and intracerebral hemorrhage with special reference to the pons.
    Kyriakides T; Silbert PL; Kakulas BA
    Clin Neuropathol; 1994; 13(2):71-6. PubMed ID: 8205729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Prisco D
    Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
    [No Abstract]   [Full Text] [Related]  

  • 40. Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model.
    Kasahara Y; Nakagomi T; Matsuyama T; Stern D; Taguchi A
    Stroke; 2012 Feb; 43(2):499-506. PubMed ID: 22033992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.